Immunoproteasome 尾5i subunit is specifically induced in chronic epileptogenic foci.
HMGB1-TLR4 axis may contribute to 尾5i subunit induction.
Selective inhibition of 尾5i subunit activity mediates anti-ictogenic effects.
尾5i subunit is a potential therapeutic target for seizure inhibition.